US IPO Week Ahead: No IPOs, but plenty of potential launches

Shutterstock photo

No IPOs are scheduled for the week ahead, unusual for mid-March. It may be due to some lingering effects from the government shutdown, as the SEC works through its backlog.

With the VIX Volatility Index comfortably below 20 and strong YTD returns in the IPO Index, the IPO market is receptive to new issuers , reinforced by this past week's trading from ShockWave Medical (SWAV +86% from IPO) and Futu Holdings (FHL; +28%).

So instead of pricings, look out for IPO launches. Futu's positive trading should encourage close competitor Up Fintech ( TIGR ) to begin marketing its deal. Jean giant  Levi Strauss ( LEVI ) and Blackstone-backed  Alight ( ALIT ) also appear to be strong candidates. Recent updates from CAR T biotech  Poseida Therapeutics  (PSTX) and hospital chain  Ardent Health  (ARDT) make those deals more likely to launch. NASH biotech Genfit (GNFT) is able to start its roadshow later in the week, and close comp Cirius Therapeutics (CSTX) may decide to join the IPO calendar as well. 

Five 2018 IPO lock-ups are expiring in the week ahead, including China-based NIO (NIO), 111 Inc (YI) and Qutoutiao (QTT), pemphigus biotech Principia Biopharma (PRNB), and Virginia-based  FVCBankcorp (FVCB). Street research is expected for medical device maker Avedro (AVDR; BofA/JPM; -16% from IPO) and biotechs TCR2 Therapeutics (TCRR; Jefferies/Leerink; 4% from IPO) and Stealth Biotherapeutics (MITO; Jefferies/Evercore; +40% form IPO).

Sign up for a free trial of our premium platform, IPO Pro . Follow us on Twitter ( @IPOtweet ) and register for our updates on the IPO market.

IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 3/7/19, the Renaissance IPO Index was up 26.8% year-to-date, while the S&P 500 had a gain of 10.1%. Renaissance Capital's IPO ETF ( IPO ) tracks the index, and top ETF holdings include VICI Properties (VICI) and Altice (ATUS). The Renaissance International IPO Index was up 8.0% year-to-date, while the ACWX was up 8.9%. Renaissance Capital's International IPO ETF ( IPOS ) tracks the index, and top ETF holdings include SoftBank and China Tower.

The article US IPO Week Ahead: No IPOs, but plenty of potential launches originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO) , Renaissance International ETF (symbol: IPOS) , or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines , IPOs
Referenced Symbols: IPO , IPOS , TIGR , LEVI , ALIT

More from Renaissance Capital


Renaissance Capital

Renaissance Capital


Research Brokers before you trade

Want to trade FX?